These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51 related articles for article (PubMed ID: 7584503)
21. Construction and characterization of a Fab recombinant protein for Japanese encephalitis virus neutralization. Wu SC; Lin YJ; Chou JW; Lin CW Vaccine; 2004 Nov; 23(2):163-71. PubMed ID: 15531033 [TBL] [Abstract][Full Text] [Related]
23. Production of a recombinant single-chain variable-fragment (scFv) antibody against sulfoglycolipid. Cheng X; Zhang Y; Kotani N; Watanabe T; Lee S; Wang X; Kawashima I; Tai T; Taniguchi N; Honke K J Biochem; 2005 Mar; 137(3):415-21. PubMed ID: 15809345 [TBL] [Abstract][Full Text] [Related]
24. Molecular selection of human antibodies with an unconventional bacterial B cell antigen. Sasano M; Burton DR; Silverman GJ J Immunol; 1993 Nov; 151(10):5822-39. PubMed ID: 8228264 [TBL] [Abstract][Full Text] [Related]
25. Overview and discovery of IgNARs and generation of VNARs. Nuttall SD Methods Mol Biol; 2012; 911():27-36. PubMed ID: 22886244 [TBL] [Abstract][Full Text] [Related]
26. [Purification of recombinant humanized anti-HBsAg Fab antibody by affinity chromatography]. Deng N; Chen WY; Xiang JJ; Rao GR; Tang Y Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Sep; 20(5):575-7. PubMed ID: 15367351 [TBL] [Abstract][Full Text] [Related]
35. Recombinant single-chain and disulfide-stabilized Fv immunotoxins for cancer therapy. Niv R; Segal D; Reiter Y Methods Mol Biol; 2003; 207():255-68. PubMed ID: 12412479 [No Abstract] [Full Text] [Related]
36. Structural aspects of conformational changes in ligand binding by antibody fragments. Edmundson AB; Guddat LW; Shan L; Fan ZC; Hanson BL Res Immunol; 1994 Jan; 145(1):56-61. PubMed ID: 8008970 [No Abstract] [Full Text] [Related]
37. NANOBODY Kunz S; Durandy M; Seguin L; Feral CC Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686035 [TBL] [Abstract][Full Text] [Related]
38. [Dependence of the specific activity of antitetanus immunoglobulin on the degree of its fragmentation]. Gavrilenkova VIu; Selezneva VP; Runova VF; Kargina TM Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):68-71. PubMed ID: 2939668 [TBL] [Abstract][Full Text] [Related]
39. The second century of the antibody. Molecular perspectives in regulation, pathophysiology, and therapeutic applications. Braun J; Saxon A; Wall R; Morrison SL West J Med; 1992 Aug; 157(2):158-68. PubMed ID: 1441467 [TBL] [Abstract][Full Text] [Related]